Ceria–Zirconia Nanoparticles as an Enhanced Multi‐Antioxidant for Sepsis Treatment

Min Soh(Seoul National University), Dong‐Wan Kang(Seoul National University Hospital), Han‐Gil Jeong(Seoul National University Hospital), Dokyoon Kim(Seoul National University), Do Yeon Kim(Seoul National University Hospital), Wookjin Yang(Seoul National University Hospital), Changyeong Song(Seoul National University), Seungmin Baik(Seoul National University), In‐Young Choi(Seoul National University Hospital), Seul‐Ki Ki(Seoul National University Hospital), Hyek Jin Kwon(Seoul National University), Taeho Kim(Seoul National University), Chi Kyung Kim(Korea University Medical Center), Seung‐Hoon Lee(Seoul National University Hospital), Taeghwan Hyeon(Seoul National University)
Angewandte Chemie International Edition
June 23, 2017
Cited by 369

Abstract

Abstract The two oxidation states of ceria nanoparticles, Ce 3+ and Ce 4+ , play a pivotal role in scavenging reactive oxygen species (ROS). In particular, Ce 3+ is largely responsible for removing O 2 − and . OH that are associated with inflammatory response and cell death. The synthesis is reported of 2 nm ceria–zirconia nanoparticles (CZ NPs) that possess a higher Ce 3+ /Ce 4+ ratio and faster conversion from Ce 4+ to Ce 3+ than those exhibited by ceria nanoparticles. The obtained Ce 0.7 Zr 0.3 O 2 (7CZ) NPs greatly improve ROS scavenging performance, thus regulating inflammatory cells in a very low dose. Moreover, 7CZ NPs are demonstrated to be effective in reducing mortality and systemic inflammation in two representative sepsis models. These findings suggest that 7CZ NPs have the potential as a therapeutic nanomedicine for treating ROS‐related inflammatory diseases.


Related Papers

No related papers found

Powered by citation graph analysis